HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Venge Selected Research

P Venge Research Topics

Disease

12Asthma (Bronchial Asthma)
10/2005 - 03/2000
9Inflammation (Inflammations)
08/2005 - 03/2000
4Ulcerative Colitis
12/2004 - 09/2001
3Myocardial Infarction
04/2011 - 05/2001
3Hypersensitivity (Allergy)
08/2004 - 05/2000
3Infections
04/2004 - 10/2000
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
06/2008 - 12/2004
2ST Elevation Myocardial Infarction
06/2006 - 05/2001
2Necrosis
03/2006 - 03/2000
2Colitis
12/2004 - 04/2002
2Allergic Rhinitis
11/2002 - 12/2001
2Virus Diseases (Viral Diseases)
11/2002 - 01/2001
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2001 - 10/2000
2Hodgkin Disease (Hodgkin's Disease)
09/2001 - 07/2001
2Bacterial Infections (Bacterial Infection)
01/2001 - 10/2000
1Oliguria
11/2015
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
11/2015
1Acute Kidney Injury (Acute Renal Failure)
11/2015
1IGA Glomerulonephritis (IGA Nephropathy)
11/2010
1Food Intolerance
08/2010
1Rheumatoid Arthritis
08/2010
1Sepsis (Septicemia)
03/2006
1Septic Shock (Toxic Shock Syndrome)
11/2004
1Common Cold
11/2002
1Proctitis
04/2002
1Rhinitis
12/2001
1Obstructive Lung Diseases (Obstructive Lung Disease)
11/2001
1Coronary Stenosis (Coronary Artery Stenosis)
10/2001
1Thrombosis (Thrombus)
10/2001
1Pathologic Constriction (Stenosis)
10/2001
1Infarction (Infarctions)
05/2001
1Chest Pain (Chest Pains)
05/2001
1Pre-Eclampsia (Preeclampsia)
01/2001
1Hypertension (High Blood Pressure)
01/2001
1Acquired Immunodeficiency Syndrome (AIDS)
01/2001
1Nasal Obstruction
12/2000
1Neoplasms (Cancer)
10/2000
1Rupture
10/2000
1Chorioamnionitis
10/2000

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
08/2010 - 03/2000
5CytokinesIBA
08/2004 - 03/2000
5Eosinophil Cationic ProteinIBA
03/2004 - 04/2000
4Biomarkers (Surrogate Marker)IBA
11/2015 - 03/2000
4Troponin T (Troponin T1)IBA
06/2006 - 10/2000
4LipocalinsIBA
04/2004 - 10/2000
3TroponinIBA
04/2011 - 10/2001
3Trinitrotoluene (TNT)IBA
06/2006 - 05/2001
3Interleukin-8 (Interleukin 8)IBA
03/2006 - 12/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2006 - 03/2000
3Interleukin-6 (Interleukin 6)IBA
08/2005 - 03/2000
3C-Reactive ProteinIBA
08/2005 - 10/2000
3AllergensIBA
11/2002 - 04/2000
2Lipocalin-2IBA
11/2015 - 10/2000
2Complement Receptors (Complement Receptor)IBA
03/2006 - 11/2004
2Interleukin-4 (Interleukin 4)IBA
12/2002 - 12/2000
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2002 - 08/2001
2Budesonide (Pulmicort)FDA LinkGeneric
06/2002 - 12/2001
2SteroidsIBA
12/2001 - 09/2001
2Chemotactic FactorsIBA
09/2001 - 02/2001
2Muramidase (Lysozyme)IBA
01/2001 - 10/2000
2Peroxidase (Myeloperoxidase)IBA
01/2001 - 03/2000
1HepcidinsIBA
11/2015
1IronIBA
11/2015
1CreatinineIBA
11/2015
1Milk Proteins (Milk Protein)IBA
11/2010
1AntigensIBA
11/2010
1Glutens (Glutelin)IBA
08/2010
1pro-brain natriuretic peptide (1-76)IBA
06/2006
1Brain Natriuretic Peptide (Natrecor)FDA Link
06/2006
1InterleukinsIBA
03/2006
1Laminin (Merosin)IBA
10/2005
1TenascinIBA
10/2005
1CollagenIBA
12/2004
1Salmeterol Xinafoate (Serevent)FDA Link
12/2002
1Fluticasone (Cutivate)FDA LinkGeneric
12/2002
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
12/2002
1Tryptases (Tryptase)IBA
11/2002
1Theophylline (Theon)FDA LinkGeneric
06/2002
1UC 10IBA
04/2002
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2002
1Interleukin-5 (Interleukin 5)IBA
09/2001
1CD30 LigandIBA
09/2001
1Interleukin-2 (IL2)IBA
02/2001
1Uric Acid (Urate)IBA
01/2001
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2001
1SelectinsIBA
01/2001
1Dietary IronIBA
01/2001
1Air Pollutants (Pollutants, Air)IBA
12/2000
1Fibrinogen (Factor I)FDA Link
10/2000
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2000
1Dalteparin (Dalteparin Sodium)FDA Link
10/2000
1LipidsIBA
10/2000
1Edetic Acid (EDTA)FDA Link
05/2000
1Indicators and Reagents (Reagents)IBA
04/2000
1antithrombin III-protease complexIBA
03/2000

Therapy/Procedure

1Aftercare (After-Treatment)
06/2002
1Immunotherapy
12/2001
1Emergency Treatment
11/2001
1Artificial Respiration (Mechanical Ventilation)
12/2000
1Therapeutics
10/2000